Serum Insulin-Like Growth Factor-I Is Positively Associated with Serum Prostate-Specific Antigen in Middle-Aged Men without Evidence of Prostate Cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 1, 2004, Pages 163-165

  Oliver, Steven E ^a   Barrass, Barney ^b   Gunnell, David J ^b   Donovan, Jenny L ^b   Peters, Tim J ^b   Persad, Raj A ^b   Gillatt, David ^c   Neal, David E ^d   Hamdy, Freddie C ^e   Holly, Jeff M P ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

AGE DISTRIBUTION; AGED; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA;

EID: 9144268882     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-03-0102     Document Type: Article

References (6)

1. Yu, H., and Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. (Bethesda), 92: 1472-1489. 2000.
2. Byrne, C., Colditz, G. A., Willett, W. C., Speizer, F. E., Pollak. M., and Hankinson, S. E. Plasma insulin-like growth factor (IGF) 1, IGF-binding protein 3, and mammographic density. Cancer Res., 60: 3744-3748, 2000.
3. Roehrbom, C. G., Boyle, P., Gould, A. L., and Waldstreicher, J. Serum prostate-specific antigen as a predictor of prostate volume in men with prostatic hyperplasia. Urology, 53: 581-589, 1999.
4. Oliver, S. E., Gunnell, D., Donovan, J., Peters, T. J., Persad, R., Gillatt, D., Pearce, A., Neal. D. E., Hamdy, F. C., and Holly, J. Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study, Int. J. Cancer, 108: 887-892, 2004.
5. Donovan, J., Mills, N., Smith, M., Brindle, L., Jacoby, A., Peters, T., Frankel, S., Neal, D., and Hamdy, F. Improving the design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. BMJ, 325: 766-770, 2002.
6. Chokkalingam, A. P., Yu-Tang, G., Deng, J., Stanczyk, F. Z., Sesterhenn, 1. A, Mostofi. F. K., Fraumeni, J. F., and Hsing, A. W. Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate. 52: 98-105. 2002.